{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:30:41Z","timestamp":1790688641606,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000617","name":"foreign and commonwealth office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100000617","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"bill and melinda gates foundation","doi-asserted-by":"publisher","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Certain clinical indications and treatments such as the use of rasburicase in cancer therapy and 8-aminoquinolines for\n                    <jats:italic>Plasmodium vivax<\/jats:italic>\n                    malaria treatment would benefit from a point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) deficiency. Three studies were conducted to evaluate the performance of one such test: the STANDARD\n                    <jats:sup>\u2122<\/jats:sup>\n                    G6PD Test (SD BIOSENSOR, South Korea). First, biological interference on the test performance was evaluated in specimens with common blood disorders, including high white blood cell (WBC) counts. Second, the test precision on fingerstick specimens was evaluated against five individuals of each, deficient, intermediate, and normal G6PD activity status. Third, clinical performance of the test was evaluated at three point-of-care settings in the United States. The test performed equivalently to the reference assay in specimens with common blood disorders. High WBC count blood samples resulted in overestimation of G6PD activity in both the reference assay and the STANDARD G6PD Test. The STANDARD G6PD Test showed good precision on multiple fingerstick specimens from the same individual. The same G6PD threshold values (U\/g Hb) were applied for a semiquantitative interpretation for fingerstick- and venous-derived results. The sensitivity\/specificity values (95% confidence intervals) for the test for G6PD deficiency were 100 (92.3\u2013100.0)\/97 (95.2\u201398.2) and 100 (95.7\u2013100.0)\/97.4 (95.7\u201398.5) for venous and capillary specimens, respectively. The same values for females with intermediate (&gt; 30% to \u2264 70%) G6PD activity were 94.1 (71.3\u201399.9)\/88.2 (83.9\u201391.7) and 82.4 (56.6\u201396.2)\/87.6(83.3\u201391.2) for venous and capillary specimens, respectively. The STANDARD G6PD Test enables point-of-care testing for G6PD deficiency.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0257560","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T13:33:34Z","timestamp":1632144814000},"page":"e0257560","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision"],"prefix":"10.1371","volume":"16","author":[{"given":"Sampa","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Myburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Bansil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Hann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Gerth-Guyette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen","family":"Ambler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Bizilj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9436-9885","authenticated-orcid":true,"given":"Stephanie","family":"Zobrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Manis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickolas A.","family":"Styke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vajra","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobi","family":"Akingbade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Kublin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1004-4395","authenticated-orcid":true,"given":"Gonzalo J.","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"issue":"3","key":"pone.0257560.ref001","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcmd.2012.01.001","article-title":"Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the \"old\" and update of the new mutations","volume":"48","author":"A Minucci","year":"2012","journal-title":"Blood cells, molecules & diseases"},{"issue":"2","key":"pone.0257560.ref002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.hoc.2015.11.006","article-title":"Glucose-6-Phosphate Dehydrogenase Deficiency","volume":"30","author":"L Luzzatto","year":"2016","journal-title":"Hematology\/oncology clinics of North America"},{"key":"pone.0257560.ref003","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-12-418","article-title":"Spatial distribution of G6PD deficiency variants across malaria-endemic regions","volume":"12","author":"RE Howes","year":"2013","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0257560.ref004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000113463","article-title":"Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants >or = 35 weeks gestation","volume":"94","author":"VK Bhutani","year":"2008","journal-title":"Neonatology"},{"issue":"4","key":"pone.0257560.ref005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5694\/mja2.50474","article-title":"Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency","volume":"212","author":"RJ Commons","year":"2020","journal-title":"Med J Aust"},{"issue":"4","key":"pone.0257560.ref006","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjh.12665","article-title":"G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications","volume":"164","author":"L Luzzatto","year":"2014","journal-title":"British journal of haematology"},{"issue":"46","key":"pone.0257560.ref007","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.15585\/mmwr.mm6846a4","article-title":"Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria\u2014United States, 2019","volume":"68","author":"JC Haston","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0257560.ref008","first-page":"1","article-title":"Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review","author":"ME Onori","year":"2021","journal-title":"Mol Biol Rep"},{"key":"pone.0257560.ref009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2020.10.002","article-title":"The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19","volume":"161","author":"SK Jain","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"pone.0257560.ref010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.arcmed.2020.06.006","article-title":"Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?","volume":"51","author":"BD Jamerson","year":"2020","journal-title":"Arch Med Res"},{"issue":"3","key":"pone.0257560.ref011","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00277-021-04395-1","article-title":"G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?","volume":"100","author":"JG Youssef","year":"2021","journal-title":"Ann Hematol"},{"key":"pone.0257560.ref012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10715762.2020.1866757","article-title":"G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19)","author":"HC Yang","year":"2021","journal-title":"Free Radic Res"},{"issue":"1","key":"pone.0257560.ref013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjh.16366","article-title":"Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline","volume":"189","author":"D Roper","year":"2020","journal-title":"British journal of haematology"},{"issue":"5","key":"pone.0257560.ref014","doi-asserted-by":"crossref","first-page":"e1003084","DOI":"10.1371\/journal.pmed.1003084","article-title":"Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis","volume":"17","author":"DA Pfeffer","year":"2020","journal-title":"PLoS medicine"},{"key":"pone.0257560.ref015","unstructured":"Pathologists CoA. Educational Discussion: Glucose-6-phosphate Dehydrogenase (G6PD): 2015-A Glucose-6-phosphate Dehydrogenase Survey (G6PD). https:\/\/documents.cap.org\/documents\/2015-a-glucose-6-phosphate-dehydrogenase.pdf 2015 ["},{"key":"pone.0257560.ref016","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12936-016-1140-x","article-title":"Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon","volume":"15","author":"HM Peixoto","year":"2016","journal-title":"Malaria journal"},{"key":"pone.0257560.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14767058.2021.1892067","article-title":"Economic evaluation of point of care universal newborn screening for glucose-6-Phosphate dehydrogenase deficiency in United States","author":"R Vidavalur","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"pone.0257560.ref018","doi-asserted-by":"crossref","first-page":"e0005602","DOI":"10.1371\/journal.pntd.0005602","article-title":"Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis","volume":"11","author":"A Devine","year":"2017","journal-title":"PLoS neglected tropical diseases"},{"issue":"2","key":"pone.0257560.ref019","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2010.09-0416","article-title":"Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency","volume":"82","author":"KE Tinley","year":"2010","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"12","key":"pone.0257560.ref020","doi-asserted-by":"crossref","first-page":"e116143","DOI":"10.1371\/journal.pone.0116143","article-title":"Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia","volume":"9","author":"A Roca-Feltrer","year":"2014","journal-title":"PloS one"},{"issue":"11","key":"pone.0257560.ref021","doi-asserted-by":"crossref","first-page":"e0206331","DOI":"10.1371\/journal.pone.0206331","article-title":"Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity","volume":"13","author":"MS Alam","year":"2018","journal-title":"PloS one"},{"key":"pone.0257560.ref022","article-title":"Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient","author":"S Pal","year":"2018","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"1","key":"pone.0257560.ref023","doi-asserted-by":"crossref","first-page":"151356","DOI":"10.1016\/j.semperi.2020.151356","article-title":"A novel point-of-care device for measuring glucose-6-phosphate dehydrogenase enzyme deficiency","volume":"45","author":"RJ Wong","year":"2021","journal-title":"Semin Perinatol"},{"issue":"4","key":"pone.0257560.ref024","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4269\/ajtmh.14-0696","article-title":"Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests","volume":"92","author":"G Bancone","year":"2015","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"3","key":"pone.0257560.ref025","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ijlh.12627","article-title":"Abrogation of red blood cell G6PD enzyme activity through Heat treatment: development of survey material for the UK NEQAS G6PD scheme","volume":"39","author":"DR Roper","year":"2017","journal-title":"International journal of laboratory hematology"},{"key":"pone.0257560.ref026","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1475-2875-12-391","article-title":"G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests","volume":"12","author":"GJ Domingo","year":"2013","journal-title":"Malaria journal"},{"issue":"3","key":"pone.0257560.ref027","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1710775","article-title":"Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria","volume":"380","author":"MVG Lacerda","year":"2019","journal-title":"The New England journal of medicine"},{"issue":"3","key":"pone.0257560.ref028","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1802537","article-title":"Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria","volume":"380","author":"A Llanos-Cuentas","year":"2019","journal-title":"The New England journal of medicine"},{"key":"pone.0257560.ref029","volume-title":"Vitamin and Mineral Nutrition Information System","author":"WHO","year":"2011"},{"issue":"11","key":"pone.0257560.ref030","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood.2019000944","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"136","author":"L Luzzatto","year":"2020","journal-title":"Blood"},{"key":"pone.0257560.ref031","first-page":"21","article-title":"Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter","volume":"5","author":"CS Chu","year":"2020","journal-title":"Wellcome open research"},{"key":"pone.0257560.ref032","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12916-015-0531-0","article-title":"Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency","volume":"13","author":"JK Baird","year":"2015","journal-title":"BMC medicine"},{"issue":"6","key":"pone.0257560.ref033","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.trsl.2014.09.009","article-title":"Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells","volume":"165","author":"JK Baird","year":"2015","journal-title":"Translational research: the journal of laboratory and clinical medicine"},{"issue":"2","key":"pone.0257560.ref034","first-page":"243","article-title":"Human glucose-6-phosphate dehydrogenase variants","volume":"45","author":"A Yoshida","year":"1971","journal-title":"Bulletin of the World Health Organization"},{"issue":"6","key":"pone.0257560.ref035","first-page":"601","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"67","author":"WHO Working Group","year":"1989","journal-title":"Bulletin of the World Health Organization"},{"key":"pone.0257560.ref036","volume-title":"Guidelines for the treatment of malaria","author":"Organization WH","year":"2015","edition":"3"},{"key":"pone.0257560.ref037","unstructured":"Prequalification WHO. In vitro diagnostic medical devices to identify Glucose-6-phosphate dehydrogenase (G6PD) activity (TSS-2) WHO PQ Diagnostics Technical Specifications Series. 2017."},{"issue":"8","key":"pone.0257560.ref038","doi-asserted-by":"crossref","first-page":"e0009649","DOI":"10.1371\/journal.pntd.0009649","article-title":"Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil","volume":"15","author":"S Zobrist","year":"2021","journal-title":"PLoS neglected tropical diseases"},{"key":"pone.0257560.ref039","article-title":"Evaluating Percentage-Based Reporting of Glucose-6-Phosphate Dehydrogenase (G6PD) Enzymatic Activity","author":"EC Calvaresi","year":"2020","journal-title":"American journal of clinical pathology"},{"issue":"7","key":"pone.0257560.ref040","doi-asserted-by":"crossref","first-page":"e0009610","DOI":"10.1371\/journal.pntd.0009610","article-title":"Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria","volume":"15","author":"AW Satyagraha","year":"2021","journal-title":"PLoS neglected tropical diseases"},{"issue":"3","key":"pone.0257560.ref041","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/ejh.13013","article-title":"Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression","volume":"100","author":"M Kalnoky","year":"2018","journal-title":"European journal of haematology"},{"issue":"4","key":"pone.0257560.ref042","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4269\/ajtmh.14-0194","article-title":"Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency","volume":"91","author":"N LaRue","year":"2014","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"6","key":"pone.0257560.ref043","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1373\/jalm.2017.024935","article-title":"Genotype\u2013Phenotype Correlations of Glucose-6-Phosphate\u2013Deficient Variants Throughout an Activity Distribution","volume":"2","author":"JL Powers","year":"2019","journal-title":"The Journal of Applied Laboratory Medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T13:34:41Z","timestamp":1632144881000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257560"}},"subtitle":[],"editor":[{"given":"Benedikt","family":"Ley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0257560","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]}}}